2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow 4Moving Biotech: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis 4P004, Placebo (NaCl 0.9%) - Knee Osteoarthritis, Synovitis of Knee | Phase 2 | Completed | 4Moving Biotech | 130 | 2025-06-17 | 2026-10-23 |
| Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee 4P-004, Placebo - Knee Osteoarthritis | Phase 1 | Completed | 4Moving Biotech | 34 | 2022-08-09 | 2025-06-26 |
Osteoarthritis, Knee (2) · Osteoarthritis (1)
Liraglutide (2) · Sodium Chloride (1)
Belgium (1) · Canada (1) · Denmark (1) · France (1) · Poland (1) · Spain (1) · United States (1)